Anutosh Ranjan Saha

Efficacy and Safety of Aripiprazole and Haloperidol Versus Placebo in Patients With Schizophrenia and Schizoaffective Disorder

John M. Kane, William H. Carson, Anutosh Ranjan Saha et al. · The Journal of Clinical Psychiatry · 2002 · 622 citations

Aripiprazole, an Antipsychotic With a Novel Mechanism of Action, and Risperidone vs Placebo in Patients With Schizophrenia and Schizoaffective Disorder

Steven G. Potkin, Anutosh Ranjan Saha, Mary J. Kujawa et al. · Archives of General Psychiatry · 2003 · 590 citations

A Placebo-Controlled, Double-Blind Study of the Efficacy and Safety of Aripiprazole in Patients With Acute Bipolar Mania

Paul E. Keck, Ronald N. Marcus, Stavros Tourkodimitris et al. · American Journal of Psychiatry · 2003 · 502 citations

Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials

Stephen R. Marder, Robert D. McQuade, Elyse Stock et al. · Schizophrenia Research · 2003 · 469 citations

Drug Safety, Psychiatry, Psychotic Disorder +10

Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia

Siegfried Kasper, Mark N. Lerman, Robert D. McQuade et al. · The International Journal of Neuropsychopharmacology · 2003 · 310 citations

Psychoactive Drug, Long-term Maintenance Treatment, Psychiatry +14